SG11201600122RA - Composition for the management of nausea and vomiting - Google Patents
Composition for the management of nausea and vomitingInfo
- Publication number
- SG11201600122RA SG11201600122RA SG11201600122RA SG11201600122RA SG11201600122RA SG 11201600122R A SG11201600122R A SG 11201600122RA SG 11201600122R A SG11201600122R A SG 11201600122RA SG 11201600122R A SG11201600122R A SG 11201600122RA SG 11201600122R A SG11201600122R A SG 11201600122RA
- Authority
- SG
- Singapore
- Prior art keywords
- nausea
- vomiting
- management
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856971P | 2013-07-22 | 2013-07-22 | |
| PCT/CA2014/050231 WO2015010194A1 (en) | 2013-07-22 | 2014-03-13 | Composition for the management of nausea and vomiting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600122RA true SG11201600122RA (en) | 2016-02-26 |
Family
ID=50877783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600122RA SG11201600122RA (en) | 2013-07-22 | 2014-03-13 | Composition for the management of nausea and vomiting |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US10028941B2 (en) |
| EP (1) | EP3024466B1 (en) |
| JP (1) | JP6379194B2 (en) |
| KR (1) | KR102242391B1 (en) |
| CN (1) | CN105492013B (en) |
| AR (1) | AR097023A1 (en) |
| AU (1) | AU2014295765B2 (en) |
| BR (1) | BR112016001474A2 (en) |
| CA (1) | CA2847022C (en) |
| CL (1) | CL2016000154A1 (en) |
| CY (1) | CY1120386T1 (en) |
| DK (1) | DK3024466T3 (en) |
| EA (1) | EA029690B1 (en) |
| ES (1) | ES2670619T3 (en) |
| HK (1) | HK1218264A1 (en) |
| HU (1) | HUE039131T2 (en) |
| IL (1) | IL243638B (en) |
| MX (1) | MX366760B (en) |
| MY (1) | MY191347A (en) |
| NO (1) | NO3086669T3 (en) |
| NZ (1) | NZ716017A (en) |
| PL (1) | PL3024466T3 (en) |
| PT (1) | PT3024466T (en) |
| SA (1) | SA516370443B1 (en) |
| SG (1) | SG11201600122RA (en) |
| TW (2) | TWI589292B (en) |
| UY (1) | UY35674A (en) |
| WO (1) | WO2015010194A1 (en) |
| ZA (1) | ZA201600383B (en) |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
| GB8524001D0 (en) | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| US4842867A (en) | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
| IT1201136B (en) | 1987-01-13 | 1989-01-27 | Resa Farma | TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF SUBSTANCES OF ACTIVE SUBSTANCES |
| US5110597A (en) | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
| US5017381A (en) | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
| US5387421A (en) | 1991-01-31 | 1995-02-07 | Tsrl, Inc. | Multi stage drug delivery system |
| NZ242065A (en) | 1991-03-26 | 1996-06-25 | Csl Ltd | Delayed release implant having a degradable or rupturable polymeric coating |
| US5260068A (en) | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
| DE19716732C2 (en) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Specific magnetosomes, processes for their preparation and their use |
| US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
| US7744916B2 (en) * | 1997-06-11 | 2010-06-29 | Umd, Inc. | Coated vaginal device for delivery of anti-migraine and anti-nausea drugs |
| FR2772615B1 (en) | 1997-12-23 | 2002-06-14 | Lipha | MULTILAYER TABLET FOR INSTANT RELEASE THEN PROLONGED ACTIVE SUBSTANCES |
| US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
| WO2000059481A1 (en) | 1999-04-06 | 2000-10-12 | Pharmaquest Ltd. | PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT |
| US6197329B1 (en) | 1999-05-03 | 2001-03-06 | Drugtech Corporation | Anti-nausea compositions and methods |
| US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
| WO2001037721A2 (en) | 1999-11-22 | 2001-05-31 | The Research Foundation Of State University Of New York | Magnetic nanoparticles for selective therapy |
| US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| US6500457B1 (en) | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| US6924273B2 (en) | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
| CA2350195C (en) | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| US6976982B2 (en) | 2001-01-09 | 2005-12-20 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
| US6997863B2 (en) | 2001-07-25 | 2006-02-14 | Triton Biosystems, Inc. | Thermotherapy via targeted delivery of nanoscale magnetic particles |
| US7704542B2 (en) | 2001-09-12 | 2010-04-27 | Xanodyne Pharmaceuticals, Inc. | Vitamin/mineral compositions with DHA |
| CA2392486A1 (en) | 2002-07-05 | 2002-12-08 | Duchesnay Inc. | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| AU2003303288B2 (en) | 2002-08-16 | 2006-12-07 | Microchips, Inc. | Controlled release device and method |
| GB0229725D0 (en) | 2002-12-19 | 2003-01-29 | Univ Wales Medicine | Haplotype partitioning and growth hormone SNPs |
| US20100221321A1 (en) | 2003-02-27 | 2010-09-02 | Innercap Technologies, Inc. | Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions |
| AU2005279729B2 (en) | 2004-09-01 | 2010-12-02 | Microchips, Inc. | Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| GB0502475D0 (en) | 2005-02-07 | 2005-03-16 | Sb Pharmco Inc | Novel compositions |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| US20070141147A1 (en) | 2005-12-21 | 2007-06-21 | Auriga Laboratories, Inc. | Sequential release pharmaceutical formulations |
| US20090004281A1 (en) | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| NZ586792A (en) | 2008-01-25 | 2012-09-28 | Gruenenthal Chemie | Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces |
| KR101190708B1 (en) | 2010-03-12 | 2012-10-12 | 주식회사 대웅제약 | Sustained-release pharmaceutical composition comprising mosapride or salt thereof |
| MX336038B (en) | 2010-04-07 | 2016-01-07 | Lupin Ltd | Controlled release pharmaceutical compositions of tapentadol. |
| EP2585052A4 (en) | 2010-06-22 | 2014-10-01 | Twi Pharmaceuticals Inc | Controlled release compositions with reduced food effect |
| WO2012112437A1 (en) | 2011-02-14 | 2012-08-23 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
| WO2012170676A1 (en) | 2011-06-08 | 2012-12-13 | Sti Pharma, Llc | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration |
| WO2013123569A1 (en) | 2012-02-22 | 2013-08-29 | Duchesnay Inc. | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| LT3326611T (en) | 2012-02-22 | 2020-08-25 | Duchesnay Inc. | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| US9452181B2 (en) | 2013-07-22 | 2016-09-27 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
-
2014
- 2014-03-13 ES ES14829076.0T patent/ES2670619T3/en active Active
- 2014-03-13 US US14/907,248 patent/US10028941B2/en not_active Expired - Fee Related
- 2014-03-13 DK DK14829076.0T patent/DK3024466T3/en active
- 2014-03-13 AU AU2014295765A patent/AU2014295765B2/en not_active Ceased
- 2014-03-13 CN CN201480046412.7A patent/CN105492013B/en not_active Expired - Fee Related
- 2014-03-13 WO PCT/CA2014/050231 patent/WO2015010194A1/en active Application Filing
- 2014-03-13 EA EA201690149A patent/EA029690B1/en unknown
- 2014-03-13 TW TW103109070A patent/TWI589292B/en not_active IP Right Cessation
- 2014-03-13 HU HUE14829076A patent/HUE039131T2/en unknown
- 2014-03-13 TW TW106104622A patent/TWI654977B/en not_active IP Right Cessation
- 2014-03-13 KR KR1020167004284A patent/KR102242391B1/en active IP Right Grant
- 2014-03-13 EP EP14829076.0A patent/EP3024466B1/en active Active
- 2014-03-13 PT PT148290760T patent/PT3024466T/en unknown
- 2014-03-13 BR BR112016001474A patent/BR112016001474A2/en not_active Application Discontinuation
- 2014-03-13 NZ NZ716017A patent/NZ716017A/en not_active IP Right Cessation
- 2014-03-13 PL PL14829076T patent/PL3024466T3/en unknown
- 2014-03-13 JP JP2016528268A patent/JP6379194B2/en not_active Expired - Fee Related
- 2014-03-13 MX MX2016000884A patent/MX366760B/en active IP Right Grant
- 2014-03-13 MY MYPI2016700064A patent/MY191347A/en unknown
- 2014-03-13 SG SG11201600122RA patent/SG11201600122RA/en unknown
- 2014-03-14 CA CA2847022A patent/CA2847022C/en not_active Expired - Fee Related
- 2014-07-22 UY UY0001035674A patent/UY35674A/en not_active Application Discontinuation
- 2014-07-22 AR ARP140102727A patent/AR097023A1/en unknown
-
2015
- 2015-10-15 NO NO15794300A patent/NO3086669T3/no unknown
-
2016
- 2016-01-17 IL IL243638A patent/IL243638B/en active IP Right Grant
- 2016-01-19 ZA ZA2016/00383A patent/ZA201600383B/en unknown
- 2016-01-21 SA SA516370443A patent/SA516370443B1/en unknown
- 2016-01-21 CL CL2016000154A patent/CL2016000154A1/en unknown
- 2016-06-03 HK HK16106354.9A patent/HK1218264A1/en not_active IP Right Cessation
-
2018
- 2018-07-03 CY CY20181100691T patent/CY1120386T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3020779A4 (en) | Heat-storage composition | |
| EP2992097A4 (en) | Compositions and methods | |
| EP2951283A4 (en) | Compositions and methods | |
| EP3030566A4 (en) | Aza-pyridone compounds and uses thereof | |
| IL241046A0 (en) | Fertilizer composition and method for preparing the same | |
| EP2948519A4 (en) | Delayed gelling agents | |
| EP2954423A4 (en) | Content sharing management | |
| EP3003039A4 (en) | Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds | |
| EP3020778A4 (en) | Adhesive-agent composition | |
| EP3008672A4 (en) | Opportunity events | |
| EP3064513A4 (en) | Polyrotaxane-containing composition | |
| EP3071534A4 (en) | Fertiliser composition | |
| GB201517616D0 (en) | Social project management | |
| EP3033392A4 (en) | Mechano-responsive composition | |
| EP2956570A4 (en) | Inorganic coating and composition | |
| EP3050567A4 (en) | Compound for activating ampk and uses thereof | |
| GB201305439D0 (en) | Statin composition | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201318102D0 (en) | Groupware management | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| HK1218264A1 (en) | Composition for the management of nausea and vomiting | |
| EP3085698A4 (en) | Pain-related compound and medicinal composition | |
| AU2013900876A0 (en) | Compounds and Methods - I | |
| AU2013900877A0 (en) | Compounds and Methods - II |